Anti-glutamate receptor antibodies in pediatric enteroviral encephalitis

Hisashi Kawashima1, Kazunori Suzuki, Gaku Yamanaka

  • 1Department of Peadiatrics, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan. hisashi@tokyo-med.ac.jp

Insights

Enteroviral encephalitis sequelae are linked to the immune response, not just viral load or inflammation. Targeting immunological factors may reduce long-term effects of this pediatric neurological disease.

Area of Science:

  • Neurology
  • Immunology
  • Pediatrics

Background:

  • Enteroviral encephalitis is a serious neurological condition in children.
  • Understanding disease markers is crucial for predicting outcomes and sequelae.

Purpose of the Study:

  • To investigate clinical symptoms and disease markers in pediatric enteroviral encephalitis.
  • To identify factors associated with the development of sequelae.

Main Methods:

  • Analysis of eight pediatric patients (9 months-5 years) diagnosed between 2000-2005.
  • Measurement of serum and cerebrospinal fluid (CSF) markers including glutamic oxaloacetic transaminase (GOT), IL-6, ferritin, diacron-reactive oxygen metabolites (d-ROM), and viral loads.
  • Detection of anti-glutamate receptor IgMdelta2 in CSF.

Main Results:

  • Elevated GOT, IL-6, and ferritin were common. High IL-6 and d-ROM in CSF were observed in 86% of cases.
  • Pleocytosis and high protein in CSF were rare. No significant difference in CSF viral load was found between patients with and without sequelae.
  • Anti-glutamate receptor IgMdelta2 was exclusively detected in the CSF of the patient with sequelae.

Conclusions:

  • Immunological phenomena, specifically anti-glutamate receptor IgMdelta2, are more closely associated with enteroviral encephalitis sequelae than inflammatory markers or viral loads.
  • Targeting the immunological response may be a potential therapeutic strategy to mitigate sequelae.
  • Further research is necessary to validate these findings and develop targeted therapies.

Related Concept Videos

Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or quantified.